antirheumatic agents

Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes
Stephen J Balevic, Daniel Weiner, Megan E B Clowse, Amanda M Eudy, Anil R Maharaj, Christoph P Hornik, Michael Cohen-Wolkowiez, Daniel Gonzalez

Lupus Science & Medicine Jan 2022, 9 (1) e000602; DOI: 10.1136/lupus-2021-000602
Dialogue: Hydroxychloroquine pharmacokinetic (PK) and exposure response in pregnancies with systemic lupus erythematosus: the importance of adherence for neonatal outcome
Bonnie Bermas, Nathalie Costedoat-Chalumeau

Lupus Science & Medicine Jan 2022, 9 (1) e000630; DOI: 10.1136/lupus-2021-000630
Infection hospitalisation in systemic lupus in Sweden
Julia F Simard, Marios Rossides, Iva Gunnarsson, Elisabet Svenungsson, Elizabeth V Arkema

Lupus Science & Medicine Sep 2021, 8 (1) e000510; DOI: 10.1136/lupus-2021-000510
Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine
Francisca Lambert-Fliszar, Sasha Bernatsky, Fares Kalache, Louis-Pierre Grenier, Christian A Pineau, Evelyne Vinet

Lupus Science & Medicine Aug 2021, 8 (1) e000519; DOI: 10.1136/lupus-2021-000519
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus
Roberta Vezza Alexander, Daniel Scott Rey, John Conklin, Vinicius Domingues, Mansoor Ahmed, Jazibeh Qureshi, Arthur Weinstein

Lupus Science & Medicine Jul 2021, 8 (1) e000528; DOI: 10.1136/lupus-2021-000528
Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial
Rachel L Randell, Lindsay Singler, Anthony Cunningham, Laura E Schanberg, Michael Cohen-Wolkowiez, Christoph P Hornik, Stephen J Balevic

Lupus Science & Medicine May 2021, 8 (1) e000494; DOI: 10.1136/lupus-2021-000494
Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy—a tertiary centre experience in an Appalachian state
Elise Danielle McVeigh, Amna Batool, Arnold Stromberg, Ahmed Abdel-Latif, Nayef Mohammed Kazzaz

Lupus Science & Medicine May 2021, 8 (1) e000467; DOI: 10.1136/lupus-2020-000467
Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre
Deanna D Hill, Amanda M Eudy, Peter J Egger, Qinggong Fu, Michelle A Petri

Lupus Science & Medicine Apr 2021, 8 (1) e000446; DOI: 10.1136/lupus-2020-000446
Rheumatologists’ perspective on hydroxychloroquine guidelines
James Winebrake, Leila Khalili, Julia Weiner, Yevgeniya Gartshteyn, Lisa Park, Anca D Askanase

Lupus Science & Medicine Nov 2020, 7 (1) e000427; DOI: 10.1136/lupus-2020-000427
Impact of COVID-19 pandemic on SLE: beyond the risk of infection
Alice Horisberger, Laura Moi, Camillo Ribi, Denis Comte

Lupus Science & Medicine May 2020, 7 (1) e000408; DOI: 10.1136/lupus-2020-000408

Log in using your username and password

Main menu

Log in using your username and password

You are here

antirheumatic agents